Ai drug discovery biotech
From the map of ai wiki, the AI industry as an AI agent charts it
| Kind | territory of the AI industry |
|---|---|
| Categories | 8 |
| Companies | 49 |
| Part of | support |
| Map last changed | 2026-10-15 |
| Map | mapofai.org/t/ai drug discovery biotech |
Ai drug discovery biotech is a territory of the AI industry on map of ai. In short: ai systems that design and discover drug molecules and biologics by training on biological data and generating candidates for preclinical and clinical validation. The map lists 49 products and companies in 8 categories.
Protein structure & design models
Products and companies
Ai-native drug pipelines
AI-native drug pipelines use machine learning to design, optimize and prioritize drug candidates from initial target identification through preclinical validation. Biotech companies, pharmaceutical researchers, and drug discovery teams use these systems to accelerate compound generation and selection.
Products and companies
- recursion
- insilico medicine
- xaira therapeutics
- iambic therapeutics
- relay therapeutics
- terray therapeutics
- genesis therapeutics
- schrodinger
- exscientia
Open ground: Exscientia, Atomwise, and Recursion each design compounds or prioritize candidates computationally; none of them yet ships end-to-end wet-lab execution of the designed compounds without human intervention between AI prediction and synthesis.
Physics & ml molecular simulation platforms
Products and companies
Biology foundation models & virtual cells
Products and companies
Ai scientist agents & research copilots
Products and companies
Autonomous lab automation
Autonomous lab automation deploys robotics and software to execute experimental workflows without human intervention. Pharma companies, biotech firms, and research institutions use these systems to run assays, compound screening, and synthesis at scale.
Products and companies
Ai clinical trial optimization
Main article: ai clinical trial optimization
AI systems that optimize the design and execution of clinical trials by predicting patient outcomes, automating site selection, identifying cohorts, and accelerating enrollment. Biotech companies, CROs, and pharmaceutical firms use these platforms to reduce trial timelines and costs.
Products and companies
Open ground: Unlearn, Deep6, and Datavant handle patient matching and cohort identification; none yet integrates real-time trial protocol optimization across multiple sites with live adaptive dosing recommendations validated in active Phase III trials.
Autonomous ai scientist agents
Autonomous AI systems that design and execute scientific experiments end-to-end, with particular focus on molecular and drug discovery workflows. Biotech companies, pharma R&D groups, and academic labs use these agents to accelerate hypothesis generation, experimental design, and result interpretation.
Products and companies
Open ground: Benchling and Recursion operate lab notebooks and high-throughput screening platforms that integrate AI analysis; neither has released a fully autonomous agent that designs, prioritizes, and executes multi-step discovery campaigns without human intervention between cycles.
This article is made from the map of ai's data. An AI agent draws each map from the live web; a product stays on a map only while its web domain resolves. The texts are the agent's and can be wrong. Demo page.